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Niemann-Pick C disease is a genetic disease with an autosomal recessive mode 
of inheritance. If we can identify the mutations in the index case, then the 
genotype of a relative person in terms of carrying the defective allels may be 
reliably determined. However, it is not currently possible to ascertain the status 
of a person from the general population, due to the complexity of NPC1 gene 
sequencing and its polymorphic nature.
Prenatal diagnosis is also possible under the conditions described below.
M.T. Vanier and colleagues made an observation: in three families, the 
possibility was suggested that  symptomatic heterozygotes was the what the 
therapists confronted, but finally it was ruled out in two of them (the third family 
could not be investigated totally). Two disease-causing NPC1 mutations had 
been identified in
each index case. In both families, the father of the proband developed progressive 
symptoms compatible with an adult onset neurologic form of Niemann-Pick 
disease type C. Subsequently, complete gene sequencing revealed one allele 
carrying the mutation transmitted to the affected child, and another (not 
transmitted) disease-causing mutation on the other allele. These individuals 
were thus NP-C1 homozygotes with an adult onset form.
These exceptional histories show quite well only some of the problems 
eventually posed by the clinical heterogeneity of NP-C and its complexities, 
and the possible underestimation of adult-onset form of the disease.
Prenatal diagnosis of NP-C should be offered to all of the couples who are at 
risk. The highest chances of a positive yield and sufficient sample for analysis 
are achieved using chorionic villus sampling (CVS) at 10-12 weeks, but one 
should be aware that they are also possible on amniotic cells.
Molecular genetic analysis is today and by far the preferred strategy, for several 
reasons. Unlike the cellular biology testing using filipin staining, it does not 
require cultured cells and a lengthy elaborate work up.
The results can be obtained much earlier in pregnancy, and the tests can basically 
be set up in any good molecular biology laboratory. However, it requires that
mutations have been identified on both alleles in the index case, or at least that 
suitable intragenic markers have been identified in the nuclear family.
Today, few laboratories offer a prenatal test using the cellular biology strategy, 
which should be considered as a last resort due to its many drawbacks. Results 
will not be reached until 5-7 weeks after the sampling; the tests are technically 
difficult; besides, they are fully reliable only when the proband has shown severe 
abnormalities. The above limitations exclude at least 15-20% of the families.
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